(HCKT) The Hackett - Overview
Sector: Technology | Industry: Information Technology Services | Exchange: NASDAQ (USA) | Market Cap: 243m USD | Total Return: -54.7% in 12m
Avg Turnover: 4.54M
EPS Trend: 30.2%
Qual. Beats: -1
Rev. Trend: 54.2%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
The Hackett Group (HCKT) is a strategic consulting and executive advisory firm specializing in digital transformation and enterprise software implementation. The company leverages an intellectual property-based platform model to deliver generative AI assessments, supply chain optimization, and specialized consulting for Oracle, SAP, and OneStream ecosystems.
Operating within the IT Consulting & Other Services sub-industry, the firm utilizes a proprietary benchmarking database to provide data-driven insights, a common business model for high-margin advisory services. The sector is currently characterized by a rapid shift toward GenAI integration as enterprises seek to automate workflows and modernize legacy application suites.
Investors can further examine the companys valuation metrics and historical performance trends by visiting ValueRay.
Founded in 1991 and headquartered in Miami, Florida, the firm serves global markets across the United States and Europe. Its service portfolio encompasses end-to-end support, from initial vendor evaluation and architecture design to offshore application maintenance and post-implementation training.
- Gen AI platform adoption accelerates high-margin consulting and executive advisory revenue
- Enterprise demand for Oracle and SAP implementation drives professional services growth
- Corporate IT spending cycles directly impact large-scale digital transformation contract volume
- Expansion of offshore delivery capabilities improves operating margins and competitive pricing
- Benchmark database intellectual property maintains high barrier to entry for strategic consulting
| Net Income: 14.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -12.27 > 1.0 |
| NWC/Revenue: 12.88% < 20% (prev 8.84%; Δ 4.04% < -1%) |
| CFO/TA 0.15 > 3% & CFO 31.0m > Net Income 14.1m |
| Net Debt (77.3m) to EBITDA (35.5m): 2.18 < 3 |
| Current Ratio: 1.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.2m) vs 12m ago -11.34% < -2% |
| Gross Margin: 39.51% > 18% (prev 0.39%; Δ 3.91k% > 0.5%) |
| Asset Turnover: 149.7% > 50% (prev 164.0%; Δ -14.30% > 0%) |
| Interest Coverage Ratio: 59.33 > 6 (EBITDA TTM 35.5m / Interest Expense TTM 506k) |
| A: 0.19 (Total Current Assets 81.7m - Total Current Liabilities 43.5m) / Total Assets 204.4m |
| B: 0.39 (Retained Earnings 79.6m / Total Assets 204.4m) |
| C: 0.15 (EBIT TTM 30.0m / Avg Total Assets 198.1m) |
| D: 0.47 (Book Value of Equity 65.5m / Total Liabilities 138.4m) |
| Altman-Z'' = 4.01 = AA |
| DSRI: 1.19 (Receivables 70.3m/62.6m, Revenue 296.6m/314.5m) |
| GMI: 0.97 (GM 39.51% / 38.51%) |
| AQI: 0.97 (AQ_t 0.47 / AQ_t-1 0.48) |
| SGI: 0.94 (Revenue 296.6m / 314.5m) |
| TATA: -0.08 (NI 14.1m - CFO 31.0m) / TA 204.4m) |
| Beneish M = -3.04 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 11.11 with a total of 360,986 shares traded.
Over the past week, the price has changed by +17.44%,
over one month by -14.41%,
over three months by -14.75% and
over the past year by -54.66%.
The Hackett has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy HCKT.
- StrongBuy: 1
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 17.7 | 59% |
P/E Trailing = 18.5192
P/E Forward = 6.3012
P/S = 0.8294
P/B = 3.6059
P/EG = 0.63
Revenue TTM = 296.6m USD
EBIT TTM = 30.0m USD
EBITDA TTM = 35.5m USD
Long Term Debt = 78.8m USD (from longTermDebt, last quarter)
Short Term Debt = 1.17m USD (from shortTermDebt, last quarter)
Debt = 83.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 2.27m
Net Debt = 77.3m USD (calculated: Debt 83.4m - CCE 6.07m)
Enterprise Value = 319.9m USD (242.6m + Debt 83.4m - CCE 6.07m)
Interest Coverage Ratio = 59.33 (Ebit TTM 30.0m / Interest Expense TTM 506k)
EV/FCF = 14.34x (Enterprise Value 319.9m / FCF TTM 22.3m)
FCF Yield = 6.97% (FCF TTM 22.3m / Enterprise Value 319.9m)
FCF Margin = 7.52% (FCF TTM 22.3m / Revenue TTM 296.6m)
Net Margin = 4.75% (Net Income TTM 14.1m / Revenue TTM 296.6m)
Gross Margin = 39.51% ((Revenue TTM 296.6m - Cost of Revenue TTM 179.4m) / Revenue TTM)
Gross Margin QoQ = 40.49% (prev 41.23%)
Tobins Q-Ratio = 1.57 (Enterprise Value 319.9m / Total Assets 204.4m)
Interest Expense / Debt = 0.61% (Interest Expense 506k / Debt 83.4m)
Taxrate = 46.00% (3.65m / 7.93m)
NOPAT = 16.2m (EBIT 30.0m * (1 - 46.00%))
Current Ratio = 1.88 (Total Current Assets 81.7m / Total Current Liabilities 43.5m)
Debt / Equity = 1.26 (Debt 83.4m / totalStockholderEquity, last quarter 66.0m)
Debt / EBITDA = 2.18 (Net Debt 77.3m / EBITDA 35.5m)
Debt / FCF = 3.47 (Net Debt 77.3m / FCF TTM 22.3m)
Total Stockholder Equity = 88.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.11% (Net Income 14.1m / Total Assets 204.4m)
RoE = 15.84% (Net Income TTM 14.1m / Total Stockholder Equity 88.9m)
RoCE = 17.90% (EBIT 30.0m / Capital Employed (Equity 88.9m + L.T.Debt 78.8m))
RoIC = 10.39% (NOPAT 16.2m / Invested Capital 156.0m)
WACC = 5.90% (E(242.6m)/V(325.9m) * Re(7.82%) + D(83.4m)/V(325.9m) * Rd(0.61%) * (1-Tc(0.46)))
Discount Rate = 7.82% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -20.0 | Cagr: -4.50%
[DCF] Terminal Value 73.10% ; FCFF base≈31.2m ; Y1≈27.3m ; Y5≈22.1m
[DCF] Fair Price = 11.00 (EV 354.4m - Net Debt 77.3m = Equity 277.1m / Shares 25.2m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 30.23 | EPS CAGR: 1.53% | SUE: -1.91 | # QB: -1
Revenue Correlation: 54.24 | Revenue CAGR: 1.67% | SUE: -0.13 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.34 | Chg30d=-17.21% | Revisions=-43% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.40 | Chg30d=-10.51% | Revisions=-43% | Analysts=3
EPS current Year (2026-12-31): EPS=1.50 | Chg30d=-9.27% | Revisions=-43% | GrowthEPS=-3.2% | GrowthRev=-7.5%
EPS next Year (2027-12-31): EPS=1.67 | Chg30d=-5.93% | Revisions=-33% | GrowthEPS=+11.0% | GrowthRev=+4.3%
[Analyst] Revisions Ratio: -43%